Comparison of two dialysis modes: nocturnal haemodialysis (NHD) and haemodiafiltration (HDF) in haemodialysis patients.

Not Applicable

Completed

• Conditions: haemodialysis; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12615000517572
• Lead Sponsor: Prof Peter Kerr

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

existing nocturnal haemodialysis patients
have been stable on NHD for at least 3 months
permanent vascular access

Exclusion Criteria

planned transplant
not able to provide consent
not able to adhere to protocol

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
serum biochemical parameters of dialysis adequacy (urea, phosphate, B2microglobulin, retinol binding protein, fetuin, FGF-23, alpha-1 microglobulin) as a composite outcome[Biochemical assessment at baseline and at the end of 2 weeks of each treatment option.];dialysate based assessment of removal of urea and phosphate[baseline and at the end of each 2-week treatment phase.]

Secondary Outcome Measures

Name	Time	Method
cardiovascular stability - as assessed by blood pressure during dialysis.[during the last dialysis session of each 2-week treatment phase.]